Meeting
2019 Genitourinary Cancers Symposium
Identification of bone involvement in patients with prostate cancer recurrence using 18F-fluciclovine PET/CT and impact on subsequent management.
Authors
Michael S Kipper
Genesis Healthcare, San Diego, CA
Michael S Kipper , Paul Dato
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Clinical Trial Registration Number
NCT02680041
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 248)
DOI
10.1200/JCO.2019.37.7_suppl.248
Abstract #
248
Poster Bd #
L5
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
A phase III, multicenter study to assess the diagnostic performance and clinical impact of 18F-DCFPyL PET/CT in men with suspected recurrence of prostate cancer (CONDOR).
First Author: Michael J. Morris
Poster
2017 ASCO Annual Meeting
Effect of Ga-68 PSMA-11 PET on management in patients with recurrent prostate cancer.
First Author: Tom Hope
Poster
2024 ASCO Genitourinary Cancers Symposium
PSMA PET imaging for evaluation of recurrent or persistent prostate cancer after primary prostate radiation.
First Author: Richard Bennett IV
Poster
2024 ASCO Genitourinary Cancers Symposium
Utility of PSMA PET/CT for imaging ductal carcinoma of the prostate.
First Author: Ahmed M. Mahmoud